Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H12N3O6S.Na |
Molecular Weight | 361.306 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC#N)C([O-])=O
InChI
InChIKey=GXCRUTWHNMMJEK-WYUVZMMLSA-M
InChI=1S/C13H13N3O6S.Na/c1-6(17)22-4-7-5-23-12-9(15-8(18)2-3-14)11(19)16(12)10(7)13(20)21;/h9,12H,2,4-5H2,1H3,(H,15,18)(H,20,21);/q;+1/p-1/t9-,12-;/m1./s1
Cephacetrile, a parenteral cephalosporin, is a broad-spectrum first generation cephalosporin antibiotic effective in Gram-positive and Gram-negative bacterial infections. It works by inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cephacetrile was used in the treatment of female pelvic inflammatory disease, meningitis and number of other systemic, respiratory and urinary infections.
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
122.2 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4479808/ |
15 mg/kg single, intravenous dose: 15 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
CEPHACETRILE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
71 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4479808/ |
15 mg/kg single, intravenous dose: 15 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
CEPHACETRILE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4479808/ |
15 mg/kg single, intravenous dose: 15 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
CEPHACETRILE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/950258
This pharmacokinetic investigation was based on the determination of serum and urinary levles of cephacetrile in 50 subjects given single intramuscular or intravenous doses of 0.5 or 1 gm of the antibiotic; 30 normal subjects, 10 patients with renal insufficiency, and 10 patients with chronic nephritis undergoing maintenance haemodialysis were included in this study.
Route of Administration:
Parenteral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4377
The MICs were 0.06 to 0.5 ug/ml for Group A Streptococcus, D. pneumoniae, and Staph. aureus, 4-6 ug/ml for E. coli and Klebsiella-Enterobacter 8-32 ug/ml for Pr. mirabilis and more than 500 ug/ml for Ps. aeruginosa. A few strains of Klebsiella and E. coli had MICs of more than 125 ug/ml.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C357
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110602
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
C76592
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
DBSALT002849
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
245-513-2
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
23239-41-0
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
m1063
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB01094MIG
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
23668837
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
87TH1FJY1N
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
DTXSID20945924
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY | |||
|
100000084897
Created by
admin on Fri Dec 15 16:30:18 GMT 2023 , Edited by admin on Fri Dec 15 16:30:18 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD